NovaBay Pharmaceuticals Inc (NBY)

[db]

NovaBay Pharmaceuticals Sees Large Drop in Short Interest (NBY)
July 28th, 2015 - 0 comments - Filed Under - by Jennifer Langley
Share on StockTwits

NovaBay Pharmaceuticals logoShares of NovaBay Pharmaceuticals (NYSE:NBY) were the target of a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 2,603,853 shares, a decline of 3.8% from the June 30th total of 2,706,651 shares, AnalystRatings.NET reports. Approximately 5.5% of the shares of the company are short sold. Based on an average daily volume of 162,065 shares, the short-interest ratio is currently 16.1 days.

Separately, Maxim Group initiated coverage on NovaBay Pharmaceuticals in a research note on Wednesday, April 29th. They set a “buy” rating and a $2.00 price target on the stock.

NovaBay Pharmaceuticals (NYSE:NBY) opened at 0.5902 on Tuesday. NovaBay Pharmaceuticals has a one year low of $0.42 and a one year high of $1.30. The stock’s 50-day moving average is $0.67 and its 200-day moving average is $0.65. The company’s market cap is $36.12 million.

NovaBay Pharmaceuticals (NYSE:NBY) last issued its quarterly earnings data on Thursday, May 14th. The company reported ($0.09) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.06) by $0.03. On average, analysts predict that NovaBay Pharmaceuticals will post $-0.2700 earnings per share for the current fiscal year.